🇺🇸 FDA
Patent

US 8648119

Controlled release immunomodulator compositions and methods for the treatment of otic disorders

granted A61KA61K39/39591A61K47/34

Quick answer

US patent 8648119 (Controlled release immunomodulator compositions and methods for the treatment of otic disorders) held by The Regents of the University of California expires Mon Feb 06 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Feb 11 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 06 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
3
CPC classes
A61K, A61K39/39591, A61K47/34, A61K9/0046, A61P